Role of Nrf2 in Parkinson’s Disease: Toward New Perspectives

Parkinson’s disease (PD) is one of the most common and chronic degenerative diseases in the central nervous system. The main pathology of PD formation is the progressive loss of dopaminergic neurons in substantia nigra and the formation of α-synuclein-rich Lewy bodies. The pathogenesis of PD is not...

Full description

Bibliographic Details
Published in:	Frontiers in Pharmacology
Main Authors:	Xin-xing Yang, Rong Yang, Feng Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Subjects:	Parkinson’s disease pathogenesis Nrf2 neuroprotection oxidative stress
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.919233/full

Similar Items

Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner
by: Bei Zhang, et al.
Published: (2019-04-01)

Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease
by: Francisca Villavicencio Tejo, et al.
Published: (2021-07-01)

Astrocytic Nrf2 Mediates the Neuroprotective and Anti-Inflammatory Effects of Nootkatone in an MPTP-Induced Parkinson’s Disease Mouse Model
by: Jung-Eun Park, et al.
Published: (2023-11-01)

α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response
by: Alberto Delaidelli, et al.
Published: (2021-06-01)

Z-ligustilide provides a neuroprotective effect by regulating the phenotypic polarization of microglia via activating Nrf2-TrxR axis in the Parkinson's disease mouse model
by: Shoujiao Peng, et al.
Published: (2024-10-01)

Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson’s Disease
by: Sandro Huenchuguala, et al.
Published: (2024-09-01)

Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson’s Disease
by: Manuj Ahuja, et al.
Published: (2022-09-01)

Role and mechanism of molecular hydrogen in the treatment of Parkinson’s diseases
by: Fengjiao Wang, et al.
Published: (2025-04-01)

Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson’s Disease with Potential Therapeutic Implications
by: Mengru Liu, et al.
Published: (2025-01-01)

Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disease
by: Pablo Duarte, et al.
Published: (2022-01-01)

Nrf2 Deficiency Exacerbates Parkinson’s Disease by Aggravating NLRP3 Inflammasome Activation in MPTP-Induced Mouse Models and LPS-Induced BV2 Cells
by: Lu R, et al.
Published: (2024-09-01)

VILIP3 attenuates neuronal apoptosis and oxidative stress via Nrf2 activation in the pathogenesis of Alzheimer’s disease
by: Shasha Huangfu, et al.
Published: (2025-06-01)

Repurposing of epalrestat for neuroprotection in parkinson’s disease via activation of the KEAP1/Nrf2 pathway
by: Huafang Jia, et al.
Published: (2025-04-01)

A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases
by: Sarmistha Saha, et al.
Published: (2022-01-01)

Neuroprotective effects of dendrobium endophytes metabolites in SH-SY5Y cells via the Nrf2/Keap1 pathway
by: Yan tian Liang, et al.
Published: (2024-03-01)

A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
by: Sibel Suzen, et al.
Published: (2022-05-01)

Novel Prenylated Indole Alkaloids with Neuroprotection on SH-SY5Y Cells against Oxidative Stress Targeting Keap1–Nrf2
by: Xueyang Xiao, et al.
Published: (2022-03-01)

Distinct Roles of Nrf1 and Nrf2 in Monitoring the Reductive Stress Response to Dithiothreitol (DTT)
by: Reziyamu Wufuer, et al.
Published: (2022-08-01)

Neuroprotective effect of acetoxypachydiol against oxidative stress through activation of the Keap1-Nrf2/HO-1 pathway
by: Yu Qi, et al.
Published: (2024-04-01)

Compensatory role of the Nrf2–ARE pathway against paraquat toxicity: Relevance of 26S proteasome activity
by: Yasuhiko Izumi, et al.
Published: (2015-11-01)

Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
by: Xiaoyan Sheng, et al.
Published: (2021-02-01)

Activation of Nrf2 in Astrocytes Suppressed PD-Like Phenotypes via Antioxidant and Autophagy Pathways in Rat and Drosophila Models
by: Qing Guo, et al.
Published: (2021-07-01)

Effects of electroacupuncture on behavioral deficits, hippocampal neuronal death and oxidative stress in rats with parkinson"s disease
by: Dingding LIU, et al.
Published: (2024-09-01)

Anti-Oxidative, Anti-Inflammatory and Anti-Apoptotic Effects of Flavonols: Targeting Nrf2, NF-κB and p53 Pathways in Neurodegeneration
by: Maja Jazvinšćak Jembrek, et al.
Published: (2021-10-01)

Oxidative Stress, Mitochondrial Dysfunction, and Neuroprotection of Polyphenols with Respect to Resveratrol in Parkinson’s Disease
by: Heng-Chung Kung, et al.
Published: (2021-07-01)

Formononetin Exerts Neuroprotection in Parkinson’s Disease via the Activation of the Nrf2 Signaling Pathway
by: Xiaotong Wang, et al.
Published: (2024-11-01)

Role of Nrf2 in Pancreatic Cancer
by: Marta Cykowiak, et al.
Published: (2021-12-01)

Neuroprotective effects of chloroform and aqueous fractions of noni juice against t-Butyl hydroperoxide-induced oxidative damage in SH-SY5Y cells
by: Jianguo Chen, et al.
Published: (2018-12-01)

Carveol, a natural monoterpene from essential oils prevents neuronal impairments associated with murine Parkinson's disease model in rats
by: Ola A. Habotta, et al.
Published: (2025-08-01)

Neuroprotective role of traditional Chinese plant extracts on Parkinson's disease; a comprehensive preclinical review
by: Rabia Anjum
Published: (2025-03-01)

Isoliquiritigenin attenuates neuroinflammation in mice model of Parkinson’s disease by promoting Nrf2/NQO-1 pathway
by: Huang Lijuan, et al.
Published: (2022-09-01)

In Vitro and In Vivo Neuroprotective Effects of Stellettin B Through Anti-Apoptosis and the Nrf2/HO-1 Pathway
by: Chien-Wei Feng, et al.
Published: (2019-05-01)

NADPH oxidase 2 activity in Parkinson's disease
by: Matthew T. Keeney, et al.
Published: (2022-08-01)

The Antinociceptive Role of Nrf2 in Neuropathic Pain: From Mechanisms to Clinical Perspectives
by: Kestutis Petrikonis, et al.
Published: (2024-08-01)

Sigma 1 Receptor Co-Localizes with NRF2 in Retinal Photoreceptor Cells
by: Shannon R. Barwick, et al.
Published: (2021-06-01)

Caffeine Modulates Oxidative Stress and Neuroinflammation in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Parkinson’s Disease in Female Mice
by: Aminat Omolola Imam-Fulani, et al.
Published: (2025-03-01)

Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson's disease
by: Ho Philip WL, et al.
Published: (2012-01-01)

Mangiferin mitigates neurological deficits and ferroptosis via NRF2/ARE pathway activation in cerebral ischemia-reperfusion rats
by: Chenjia Peng, et al.
Published: (2025-05-01)

Vanillylacetone attenuates cadmium chloride-induced hippocampal damage and memory loss through up-regulation of nuclear factor erythroid 2-related factor 2 gene and protein expression
by: Fahaid H AL-Hashem, et al.
Published: (2024-01-01)

Icariside II suppresses ferroptosis to protect against MPP+-Induced Parkinson's disease through Keap1/Nrf2/GPX4 signaling
by: Wenbo Fan, et al.
Published: (2023-01-01)